Amgen Inc.
AMGN
$274.40
-$1.99-0.72%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 33.51B | 32.78B | 32.03B | 31.14B | 29.54B |
| Total Other Revenue | 1.41B | 1.35B | 1.40B | 1.39B | 1.39B |
| Total Revenue | 34.92B | 34.13B | 33.42B | 32.53B | 30.93B |
| Cost of Revenue | 9.30B | 9.20B | 9.11B | 10.85B | 9.35B |
| Gross Profit | 25.62B | 24.92B | 24.32B | 21.69B | 21.59B |
| SG&A Expenses | 6.88B | 6.98B | 7.10B | 7.01B | 6.73B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 227.00M | 32.00M | 39.00M | -804.00M | -77.00M |
| Total Operating Expenses | 22.81B | 22.32B | 22.20B | 22.82B | 21.40B |
| Operating Income | 12.11B | 11.81B | 11.22B | 9.71B | 9.53B |
| Income Before Tax | 7.42B | 6.65B | 4.61B | 4.68B | 3.53B |
| Income Tax Expenses | 805.00M | 717.00M | 519.00M | 449.00M | 395.00M |
| Earnings from Continuing Operations | 6.62K | 5.93K | 4.09K | 4.23K | 3.13K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.62B | 5.93B | 4.09B | 4.23B | 3.13B |
| EBIT | 12.11B | 11.81B | 11.22B | 9.71B | 9.53B |
| EBITDA | 17.52B | 17.28B | 16.70B | 15.15B | 14.47B |
| EPS Basic | 12.31 | 11.04 | 7.62 | 7.88 | 5.85 |
| Normalized Basic EPS | 11.30 | 10.71 | 10.09 | 7.95 | 8.22 |
| EPS Diluted | 12.23 | 10.96 | 7.55 | 7.81 | 5.81 |
| Normalized Diluted EPS | 11.22 | 10.62 | 10.01 | 7.89 | 8.17 |
| Average Basic Shares Outstanding | 2.15B | 2.15B | 2.15B | 2.15B | 2.14B |
| Average Diluted Shares Outstanding | 2.17B | 2.17B | 2.16B | 2.16B | 2.16B |
| Dividend Per Share | 9.26 | 9.13 | 9.00 | 8.88 | 8.76 |
| Payout Ratio | 75.15% | 82.64% | 118.14% | 112.70% | 150.06% |